期刊文献+

Graft-versus-host disease after liver transplantation:A comprehensive literature review 被引量:16

Graft-versus-host disease after liver transplantation:A comprehensive literature review
下载PDF
导出
摘要 AIM: To determine the factors affecting mortality in pa- tients who developed graft-versus-host disease (GvHD) after liver transplantation (LT). METHODS: We performed a review of studies of GvHD following LT published in the English literature and ac- cessed the PubMed, Medline, EBSCO, EMBASE, and Google Scholar databases. Using relevant search phras- es, 88 articles were identified. Of these, 62 articles con- raining most of the study parameters were considered eligible for the study. Risk factors were first examined using a univariate Kaplan-Meier model, and variables with a significant association (P 〈 0.05) were then sub- jected to multivariate analyses using a Cox proportional- hazards model. RESULTS: The 61 articles reported 87 patients, 58 male and 29 female, mean age, 40.4 ± 15.5 years (range: 8 mo to 74 years), who met the inclusion criteria for the present study. Deaths occurred in 59 (67.8%) patients, whereas 28 (32.2%) survived after a mean follow-up period of 280.8 ± 316.2 d (range: 27-2285 d). Among the most frequent symptoms were rash (94.2%), fever (66.6%), diarrhea (54%), and pancytopenia (54%). The average time period between LT and first symptom on- set was 60.6 ± 190.1 d (range: 2-1865 d). The Kaplan- Meier analysis revealed that pancytopenia (42.8% vs 59.3%, P = 0.03), diarrhea (39.2% vs 61.0%, P = 0.04), age difference between the recipient and the donor (14.6 ± 3.1 years vs 22.6 ± 2.7 years, P 〈 0.0001), and time From first symptom occurrence to diagnosis or treatment (13.3 ± 2.6 mo vs 15.0 ± 2.3 mo, P 〈 0.0001) were significant factors affecting mortality, whereas age, sex, presence of rash and fever, use of immunosuppressive agents, acute rejection before GvHD, etiological causes, time of onset, and donor type were not associated with mortality risk. The Cox proportional-hazards model, de- termined that an age difference between the recipient and donor was an independent risk Factor (P = 0.03; hazard ratio, 7.395, 95% confidence interval, 1.2-46.7). CONCLUSION: This study showed that an age differ- ence between the recipient and donor is an independent risk factor for mortality in patients who develop GvHD after LT. AIM:To determine the factors affecting mortality in patients who developed graft-versus-host disease (GvH) after liver transplantation (LT) METHODS:We performed a review of studies of GvH following LT published in the English literature and accessed the PubMed, Medline, EBSCO, EMBASE, and Google Scholar databases Using relevant search phrases, 88 articles were identified. Of these, 61 articles containing most of the study parameters were considered eligible for the study. Risk factors were first examined using a univariate Kaplan-Meier model, and variables with a significant association (P < 0 05) were then subjected to multivariate analyses using a Cox proportional-hazards model RESULTS:The 61 articles reported 87 patients, 58 male and 29 female, mean age, 40.4 ± 15.5 years (range:8 mo to 74 years), who met the inclusion criteria for the present study. Deaths occurred in 59 (67.8%) patients, whereas 28 (32.2%) survived after a mean follow-up period of 280.8 ± 316.2 d (range:27-2285 d). Among the most frequent symptoms were rash (94.2%), fever (66.6%), diarrhea (54%), and pancytopenia (54%). Theaverage time period between LT and first symptom onset was 60.6 ± 190.1 d (range: 2-1865 d). The Kaplan-Meier analysis revealed that pancytopenia (42.8% vs 59.3%,P = 0.03), diarrhea (39.2%vs 61.0%,P = 0 04), age difference between the recipient and the donor (14.6 ± 3.1 yearsvs 22.6 ± 2.7 years,P < 0.0001), and time from first symptom occurrence to diagnosis or treatment (13.3 ± 2.6 mo vs 15.0 ± 2.3 mo, P < 0.0001) were significant factors affecting mortality, whereas age, sex, presence of rash and fever, use of immunosuppressive agents, acute rejection before GvH , etiological causes, time of onset, and donor type were not associated with mortality risk The Cox proportional-hazards model, determined that an age difference between the recipient and donor was an independent risk factor (P = 0 03; hazard ratio, 7.395, 95% confidence interval, 1.2-46.7). CONCLUSION:This study showed that an age difference between the recipient and donor is an independent risk factor for mortality in patients who develop GvH after LT.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第37期5240-5248,共9页 世界胃肠病学杂志(英文版)
关键词 Liver transplantation Graft-versus-host dis-ease IMMUNOSUPPRESSION RASH PANCYTOPENIA Diar-rhea CHIMERISM Age factors 移植物抗宿主病 肝移植 平均年龄 文献 风险因素 风险模型 时间周期 危险因素
  • 相关文献

参考文献1

二级参考文献11

  • 1贺强,韩东冬,陈大志,郎韧,李宁,秦建民,樊华.肝移植术后移植物抗宿主病的初步临床探讨[J].肝胆外科杂志,2006,14(2):91-94. 被引量:8
  • 2Billingham RE.The biology of graft-versus-host reactions[].Harvey Lect.1966
  • 3Vogelsang GB,Lee L,Bensen-Kennedy DM.Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant[].Annu Rev Med.2003
  • 4Sudhindran S,Taylor A,Delriviere L,Collins VP,Liu L,Taylor CJ,Alexander GJ,Gimson AE,Jamieson NV,Watson CJ,Gibbs P.Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection[].American Journal of Transplantation.2003
  • 5Przepiorka D,Kernan NA,Ippoliti C,Papadopoulos EB,Giralt S,Khouri I,Lu JG,Gajewski J,Durett A,Cleary K,Champlin R,Andersson BS,Light S.Daclizumab, a humanized anti- interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease[].Blood.2000
  • 6Liang TB,Tang XF,Zheng SS,Lu AW,Wang WL,Shen Y,Zhang M,Meng XQ.Graft versus host disease after liver transplantation: a report of 3 cases[].Zhonghua Yixue Zazhi.2004
  • 7Schlitt HJ,Kanehiro H,Raddatz G,Steinhoff G,Richter N,Nashan B,Ringe B,Wonigeit K,Pichlmayr R.Persistence of donor lymphocytes in liver allograft recipients[].Transplantation.1993
  • 8Hahn AB,Baliga P.Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation[].Liver Transpl.2000
  • 9Schrager JJ,Vnencak-Jones CL,Graber SE,Neff AT,Chari RS,Wright KJ Jr,Pinson CW,Stewart JH,Gorden DL.Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients[].Transplantation.2006
  • 10Domiati-Saad R,Klintmalm GB,Netto G,Agura ED,Chinnakotla S,Smith DM.Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism[].Am J Transplant.2005

共引文献7

同被引文献71

引证文献16

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部